Arcus Biosciences, Inc.

Rachunek Zysków i Strat





index 0 1 2 3 4 5 6 7 8
Rok finansowy 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 0 1 8 15 78 383 112 117 258
Przychód Δ r/r 0.0% inf% 491.2% 79.6% 416.8% 393.9% -70.7% 4.5% 120.5%
Marża brutto 0.0% 100.0% 100.0% -423.2% -105.1% 98.2% 87.5% 86.3% 100.0%
EBIT (mln) -18 -53 -55 -89 -124 54 -280 -340 -330
EBIT Δ r/r 0.0% 193.9% 2.7% 61.7% 40.0% -143.7% -616.1% 21.4% -2.9%
EBIT (%) 0.0% -3782.1% -656.8% -591.4% -160.3% 14.2% -250.0% -290.6% -127.9%
Koszty finansowe (mln) 0 0 5 0 0 0 2 2 4
EBITDA (mln) -17 -51 -56 -89 -125 55 -264 -291 -269
EBITDA(%) 0.0% -3597.2% -671.5% -591.4% -161.1% 14.3% -235.7% -248.7% -104.3%
Podatek (mln) 0 0 5 -9 -6 2 1 6 1
Zysk Netto (mln) -18 -53 -50 -76 -117 53 -267 -307 -283
Zysk netto Δ r/r 0.0% 195.4% -6.6% 53.1% 53.7% -145.4% -603.8% 15.0% -7.8%
Zysk netto (%) 0.0% -3756.7% -593.7% -506.2% -150.5% 13.8% -238.4% -262.4% -109.7%
EPS -0.73 -1.25 -1.43 -1.73 -2.13 0.76 -3.71 -4.15 -3.14
EPS (rozwodnione) -0.73 -1.25 -1.43 -1.73 -2.13 0.71 -3.71 -4.15 -3.14
Ilośc akcji (mln) 25 43 35 44 55 69 72 74 90
Ważona ilośc akcji (mln) 25 43 35 44 55 74 72 74 90
Waluta USD USD USD USD USD USD USD USD USD